In Boston, Swiss specialty chemicals giant Givaudan has partnered with Ginkgo Bioworks to enable fermentation-based production processes for ingredients that are in demand but only available in minute quantities in nature. Under the terms of the deal, Ginkgo will use its cell programming platform to develop organisms that produce these rare products at high yields. The collaboration between Ginkgo and Givaudan spans multiple programs, with the possibility of adding more in the future.
“Through this close collaboration, we will be able to help Givaudan transform even the rarest and most complex nature-inspired ingredients into more sustainable products for consumers,” says Jason Kelly, CEO at Ginkgo Bioworks. “We believe that biology has the power to enable better and more sustainable products across many industries, from flavors and fragrances, to pharmaceuticals, to farming.”
Ginkgo expects to go public later this year via a merger with SPAC Soaring Eagle Acquisition Corp.